alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › ptau217

ptau217

3 studies tagged ptau217, dated 2024-05-23 to 2025-08-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients 2025-08-01
  2. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment 2024-10-16
  3. Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET 2024-05-23

Studies

3 studies carry this tag.

Date range

2024 to 2025

Top journals

  • Brain communications 1
  • Journal of neurochemistry 1
  • Journal of neurology, neurosurgery, and psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Journal of neurochemistry 2025-08-01 Biomarkers

    Alzheimer's disease (AD) is characterized by brain protein depositions, impaired synaptic transmission, and progressive cognitive decline.

  2. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of neurology, neurosurgery, and psychiatry 2024-10-16 Biomarkers

    Plasma pTau217 and pTau181 both correlate with AD, but the fold change in pTau217 makes it better to diagnose cerebral amyloidosis, and predict cognitive decline and conversion to AD dementia.

  3. Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Brain communications 2024-05-23 Biomarkers

    These findings indicate that plasma pTau181, plasma pTau217 and amyloid-β PET convey overlapping information and therefore predict the dynamic phase of asymptomatic amyloid-β accumulation with comparable performances.

All topic tags with their study counts